What is Pfizer Limited's latest revenue?

Pfizer Limited reported revenue of ₹2,520 Cr in its latest annual results, per the filed results.

What is Pfizer Limited's latest net profit?

Pfizer Limited reported net profit of ₹722 Cr in its latest annual results, per the filed results.

What is Pfizer Limited's return on equity?

Pfizer Limited posted ROE of 17.5% and ROCE of 23.2% for its latest annual results, computed from filed statements.

What is Pfizer Limited's operating margin?

Pfizer Limited's operating margin was 34.7% in its latest annual results, derived from filed operating expenses.

PFI

PFIZER

Name: Pfizer Limited (PFIZER) quarterly results & financial statements
Creator: Upmazing

Pfizer Limited

HealthcareNIFTY Smallcap 250

ISIN INE182A01018

—

Day

52W

MCap₹21,088 Cr

fairUpmazing Score

Open chart ↗

PFI

PFIZER

Pfizer Limited

HealthcareNIFTY Smallcap 250

ISIN INE182A01018

—

Day

52W

MCap₹21,088 Cr

fairUpmazing Score

Open chart ↗

Pfizer Limited (PFIZER) reported revenue of ₹653 Cr and net profit of ₹204 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.

PFIZER fundamentals, Fundamental score 93/100

The statements below are read from Pfizer Limited’s filed results, 28 filed quarters and 11 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.

Latest: Q1 FY26-27 · filed Jul 29, 2026 · audited

Sales CAGR · 3Y+1.3%FY22 → FY25

Sales CAGR · 4Y−0.9%FY21 → FY25

PAT CAGR · 3Y+5.0%FY22 → FY25

PAT CAGR · 4Y+4.2%FY21 → FY25

Price · 1Y−10.6%EOD

Price CAGR · 3Y+6.0%EOD

Quarterly resultsStandalone

₹ Cr	Dec2018	Jun2019	Sep2019	Dec2019	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026Latest	YoYlatest
Sales	514	544	567	538	595	593	535	749	636	676	550	593	637	622	573	531	575	540	547	563	589	538	592	603	642	645	629	653	+8.3%
	359	378	403	405	392	397	409	463	447	481	384	401	406	418	391	421	393	387	357	385	399	392	364	393	412	417	393	406	+3.2%
Operating profit	154	166	164	133	203	197	126	286	189	195	165	192	232	203	182	111	183	153	189	177	189	146	228	210	230	228	236	248	+17.9%
OPM %	30.0%	30.5%	29.0%	24.8%	34.1%	33.2%	23.5%	38.1%	29.8%	28.9%	30.1%	32.4%	36.3%	32.7%	31.8%	20.8%	31.7%	28.3%	34.7%	31.5%	32.2%	27.1%	38.4%	34.8%	35.8%	35.4%	37.5%	37.9%	+3.1 pp
Other income	64.4	35.8	44.8	58.2	12.2	14.6	37.2	12.2	15.0	18.3	17.1	18.0	24.2	27.4	31.4	33.5	36.1	35.9	75.1	41.8	43.1	42.8	44.6	67.2	41.9	38.2	40.7	44.8	-33.2%
Interest	0.29	2.15	2.62	2.46	4.71	3.85	3.54	2.25	2.21	2.18	3.85	3.64	3.38	3.84	2.53	2.87	2.73	2.86	6.95	2.11	2.10	1.51	2.69	3.25	2.13	1.99	2.11	1.46	-55.1%
Depreciation	17.8	25.0	25.1	24.7	27.7	27.2	27.3	27.0	27.2	27.2	33.6	26.5	26.3	26.3	26.4	15.6	15.4	17.6	13.8	14.6	15.0	14.8	16.4	14.4	14.3	14.3	14.8	14.3	-1.0%
Profit before tax	201	175	181	165	183	180	132	269	175	184	145	43.4	415	201	165	126	201	176	244	203	215	172	426	260	255	192	269	277	+6.6%
Tax %	34.2%	35.5%	14.9%	15.5%	28.2%	21.6%	23.9%	25.6%	18.3%	21.8%	13.3%	25.0%	25.1%	24.9%	21.3%	25.6%	25.7%	26.1%	26.7%	25.6%	26.4%	26.0%	22.3%	26.1%	26.0%	26.1%	25.7%	26.1%	-0.0 pp
Net profit	132	113	154	139	131	141	101	200	143	144	126	32.6	311	151	130	93.5	149	130	179	151	158	128	331	192	189	142	200	204	+6.6%
EPS (₹)	28.84	24.66	33.72	30.40	28.71	30.87	21.98	43.69	31.25	31.46	27.50	7.11	67.99	32.93	28.34	20.44	32.56	27.12	22.33	32.94	34.61	27.89	72.34	41.91	41.32	31.01	43.68	44.69	+6.6%

One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters

Revenue & net profit trend

last 20 quarters

RevenueNet profit

Revenue & net profit — Standalone20 quarters

Segment results

Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.

Forensic checksauto-scanned from the filing

Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.

How results moved the priceEOD reaction on the session the market could trade the filing

Avg absolute result-day move ±1.7%· EPS surprise: no estimates source· 4 earlier quarters have no dated filing on record

Q1'27filed Tue 28 Jul 14:04 · traded that sessiongap +0.2%close +0.4%

Q4'26filed Tue 12 May 21:10 · first tradeable session Wed 13 Maygap −1.6%close −2.4%

Q3'26filed Mon 9 Feb 19:34 · first tradeable session Tue 10 Febgap +3.5%close +4.1%

Q2'26filed Wed 12 Nov 16:27 · first tradeable session Thu 13 Novgap +3.0%close +0.6%

Q1'26filed Wed 13 Aug 16:58 · first tradeable session Thu 14 Auggap +3.4%close +4.3%

Q4'25filed Tue 20 May 17:13 · first tradeable session Wed 21 Maygap −0.1%close +0.6%

Q3'24filed Fri 9 Feb 14:40 · traded that sessiongap +0.7%close −3.4%

Q2'24filed Sat 28 Oct 15:26 · traded that sessiongap −2.2%close +0.2%

Q1'24filed Fri 11 Aug 16:29 · first tradeable session Mon 14 Auggap −1.5%close −3.0%

Q4'23filed Mon 15 May 17:53 · first tradeable session Tue 16 Maygap +0.8%close −0.0%

Q3'23filed Thu 9 Feb 16:42 · first tradeable session Fri 10 Febgap +1.0%close +2.9%

Q2'23filed Fri 11 Nov 16:15 · first tradeable session Mon 14 Novgap +5.0%close +3.9%

Q1'23filed Fri 5 Aug 15:10 · traded that sessiongap +0.1%close −1.5%

Q4'22filed Fri 20 May 19:38 · first tradeable session Mon 23 Maygap +0.1%close +1.3%

Q3'22filed Thu 3 Feb 16:36 · first tradeable session Fri 4 Febgap +0.3%close −2.1%

Q2'22filed Wed 3 Nov 18:23 · first tradeable session Thu 4 Novgap −0.5%close −0.3%

Q1'22filed Wed 28 Jul 14:18 · traded that sessiongap +0.9%close +0.1%

Q4'21filed Wed 26 May 16:27 · first tradeable session Thu 27 Maygap −0.9%close −2.6%

Q3'21filed Fri 5 Feb 16:09 · first tradeable session Mon 8 Febgap +1.5%close −0.4%

Q2'21filed Mon 2 Nov 13:52 · traded that sessiongap +1.1%close −0.0%

PeriodQ1 FY26-27BasisStandaloneFiledJul 29, 2026Qualityaudited

Frequently Asked Questions

What is Pfizer Limited's latest revenue?: Pfizer Limited reported revenue of ₹2,520 Cr in its latest annual results, per the filed results.
What is Pfizer Limited's latest net profit?: Pfizer Limited reported net profit of ₹722 Cr in its latest annual results, per the filed results.
What is Pfizer Limited's return on equity?: Pfizer Limited posted ROE of 17.5% and ROCE of 23.2% for its latest annual results, computed from filed statements.
What is Pfizer Limited's operating margin?: Pfizer Limited's operating margin was 34.7% in its latest annual results, derived from filed operating expenses.